These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29302118)

  • 1. Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital.
    Khan JH; Green EA; Chang J; Ayala AM; Barkin MS; Reinys EE; Stanton J; Stanten RD
    J Extra Corpor Technol; 2017 Dec; 49(4):273-282. PubMed ID: 29302118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital Are Maintained 4 Years after Initiation.
    Khan JH; Barkin MS; Stanton J; Khan A; Stanten RD
    J Extra Corpor Technol; 2022 Mar; 54(1):35-41. PubMed ID: 36380821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage.
    Fleming K; Redfern RE; March RL; Bobulski N; Kuehne M; Chen JT; Moront M
    J Extra Corpor Technol; 2017 Dec; 49(4):283-290. PubMed ID: 29302119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital.
    Vonk AB; Meesters MI; van Dijk WB; Eijsman L; Romijn JW; Jansen EK; Loer SA; Boer C
    Transfusion; 2014 Oct; 54(10 Pt 2):2608-16. PubMed ID: 24372139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood utilization in revision versus first-time cardiac surgery: an update in the era of patient blood management.
    Hensley NB; Kostibas MP; Yang WW; Crawford TC; Mandal K; Gupta PB; Frank SM; Brown CH
    Transfusion; 2018 Jan; 58(1):168-175. PubMed ID: 28990242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A change in anticoagulation monitoring improves safety, reduces transfusion, and reduces costs in infants on cardiopulmonary bypass.
    Machovec KA; Jooste EH; Walczak RJ; Homi HM; Jaquiss RD; Lodge AJ; Ames WA
    Paediatr Anaesth; 2015 Jun; 25(6):580-6. PubMed ID: 25530420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior blood-saving effect and postoperative recovery of comprehensive blood-saving strategy in infants undergoing open heart surgery under cardiopulmonary bypass.
    Wu T; Liu J; Wang Q; Li P; Shi G
    Medicine (Baltimore); 2018 Jul; 97(27):e11248. PubMed ID: 29979388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in blood transfusion in a cohort of infants having cardiac surgery with cardiopulmonary bypass after instituting a goal-directed transfusion policy.
    Machovec KA; Smigla G; Ames WA; Schwimer C; Homi HM; Dhakal IB; Jaquiss RD; Lodge AJ; Jooste EH
    Perfusion; 2016 Oct; 31(7):598-603. PubMed ID: 27015916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Protamine Titration-Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery.
    Abuelkasem E; Mazzeffi MA; Henderson RA; Wipfli C; Monroe A; Strauss ER; Chow JH; Tanaka KA
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2153-2160. PubMed ID: 30737123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a transfusion algorithm to reduce blood product utilization in pediatric cardiac surgery.
    Whitney G; Daves S; Hughes A; Watkins S; Woods M; Kreger M; Marincola P; Chocron I; Donahue B
    Paediatr Anaesth; 2013 Jul; 23(7):639-46. PubMed ID: 23506389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Conservation and Hemostasis in Cardiac Surgery: A Survey of Practice Variation and Adoption of Evidence-Based Guidelines.
    Joshi RV; Wilkey AL; Blackwell JM; Kwak J; Raphael J; Shore-Lesserson L; Greilich PE
    Anesth Analg; 2021 Jul; 133(1):104-114. PubMed ID: 33939648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell salvage during coronary artery bypass surgery and allogenic blood exposure.
    Al-Mandhari S; Maddali MM; Al-Bahrani MJ
    Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):913-6. PubMed ID: 26113735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program.
    Xydas S; Magovern CJ; Slater JP; Brown JM; Bustami R; Parr GV; Thurer RL
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):926-35. PubMed ID: 22285327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.
    Xie Y; Shen S; Zhang J; Wang W; Zheng J
    Int J Med Sci; 2015; 12(4):322-8. PubMed ID: 25897293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood conservation strategies in cardiac surgery: more is better.
    Avgerinos DV; DeBois W; Salemi A
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):865-70. PubMed ID: 24482391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 0.6-protamine/heparin ratio in cardiac surgery is associated with decreased transfusion of blood products.
    Goedhart ALM; Gerritse BM; Rettig TCD; van Geldorp MWA; Bramer S; van der Meer NJM; Boonman-de Winter LJ; Scohy TV
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):391-397. PubMed ID: 32620960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of On-Bypass Red Blood Cell Transfusion on Severe Postoperative Morbidity or Mortality in Children.
    Willems A; Datoussaid D; Tucci M; Sanchez Torres C; De Villé A; Fils JF; Van der Linden P
    Anesth Analg; 2016 Aug; 123(2):420-9. PubMed ID: 27331784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies.
    Arora RC; Légaré JF; Buth KJ; Sullivan JA; Hirsch GM
    Ann Thorac Surg; 2004 Nov; 78(5):1547-54. PubMed ID: 15511428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.